drugset / Trial / NCT00069849
A Study of the Safety and Efficacy of Multiple Doses of ABT-089 in Subjects With Alzheimer's Disease
RandomizedCrossoverDouble-blindTreatment
Summary
The purpose of this study is to compare the safety and efficacy of 2 mg, 4 mg, and 20 mg of ABT-089 BID to placebo in adults with Alzheimer's disease.
Timeline
- Start
- 2003-07
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pozanicline | Small molecule | 2 mg | — |
| Subject | Pozanicline | Small molecule | 4 mg | — |
| Subject | Pozanicline | Small molecule | 20 mg | — |